Skip to main content
. 2020 Dec 11;15(12):e0243872. doi: 10.1371/journal.pone.0243872

Table 5. Association of FGF-23 with annualized relative change in cognitive vitality test scores.

N = 843 participants Model 1 Model 2 Model 3
Outcome* β (95% CI) β (95% CI) β (95% CI)
3MS Score 0.07 (-0.17, 0.31) 0.03 (-0.21, 0.26) 0.03 (-0.21, 0.26)
DST score -0.04 (-1.56, 1.48) 0.06 (-1.43, 1.54) 0.09 (-1.39, 1.58)
Verbal Memory  
    Immediate Recall -0.15 (-1.96, 1.67) -0.58 (-2.33, 1.17) -0.55 (-2.33, 1.19)
    Delayed recall -0.42 (-1.28, 0.44) -0.56 (-1.43, 0.31) -0.54 (-1.42, 0.33)
Psychomotor Speed 0.42 (-0.26, 1.09) 0.33 (-0.33, 0.98) 0.34 (-0.33, 0.98)
Perceptual Speed 0.47 (-0.50, 1.45) 0.33 (-0.62, 1.28) 0.33 (-0.62, 1.28)
Depression 0.62 (-2.08, 3.32) 0.45 (-2.24, 3.13) 0.42 (-2.26, 3.11)
Executive Function  
    CLOX1 -0.46 (-1.22, 0.31) -0.32 (-1.07, 0.42) -0.32 (-1.07, 0.43)

Model 1 = unadjusted analysis.

Model 2 = adjusted for age, sex, race, study site, education, diabetes, cardiovascular disease, hypertension, eGFR and urine ACR.

Model 3 = M2 + calcium, phosphorus, PTH, 25(OH) Vitamin D and klotho.

*All dependent variables were log transformed.

** FGF-23 was log transformed.

*** Coefficient interpretation example 3MSE & FGF-23: Every two fold higher FGF-23 is associated with a 0.07% decline in 3MSE score.